Clinical trial
Pentasa Once Daily in Ulcerative Colitis for Maintenance of Remission
NCT00209300 · Ferring Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00209300 |
|---|---|
| Title | Pentasa Once Daily in Ulcerative Colitis for Maintenance of Remission |
| Official title | Pentasa Once Daily in Ulcerative Colitis for Maintenance of Remission. A European Multi-centre Investigator Blinded Randomized Controlled Study of Pentasa Sachet Comparing One Gram Twice With Two Grams Once Daily |
| Lead sponsor | Ferring Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Ulcerative Colitis |
| Intervention type | Drug |
| Interventions | Pentasa |
| Enrollment | 362 |
| Start date | May 1, 2005 |
| Primary completion | May 1, 2007 |
| Completion | Jun 1, 2007 |
| First posted | Sep 21, 2005 |
| Last update posted | May 19, 2011 |
| Countries | Belgium, Czechia, Denmark, Finland, Germany, Netherlands, Norway, Sweden |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: